JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer

NCT02591433 | Withdrawn

• 2 other identifiers: 13D.423JT 2686
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

This pilot clinical trial studies how well the "JeffQuit" group therapy program works in enabling patients with a history of cancer to quit smoking. The JeffQuit program uses group therapy to provide psychological support and address the mental need for smoking, the habit or routine it creates, and the physical need for nicotine. It is not yet known how well the JeffQuit program will work in helping patients with a history of cancer to stop smoking.

Conditions

Current Smoker; Malignant Neoplasm

Outcome Measures

Primary Outcomes (1)

• Proportion of patients who are adherent to smoking abstinence

  Calculated along with a 1-sided 95% exact confidence interval. An exact binomial test (with a one-sided alpha of 0.05) will also be used to test whether adherence is greater than 60%.

  Up to 6 months after completion of intervention

Secondary Outcomes (2)

• Change in Patient Reported Outcomes Measurement Information System (PROMIS) quality of life scores

  Baseline to up to 6 months after completion of intervention

• Change in Smoking Cessation Quality of Life (SCQoL) questionnaire scores

  Baseline to up to 6 months after completion of intervention

Study Arms (1)

Supportive care (JeffQuit group therapy)

EXPERIMENTAL

Patients undergo three, 1-hour group therapy sessions held by a JeffQuit practitioner over a 1-month period. Patients receive strategies for managing the psychological, habitual, and physiological components of smoking and help with developing a planned quit date. Patients are also provided with advice on how to switch to cigarette brands with less nicotine and then how to substitute the nicotine patch and gum for cigarettes. The JeffQuit counselor is available for additional individual support as needed.

Other: Tobacco Cessation Counseling; Other: Support Group Therapy; Other: Quality-of-Life Assessment

Interventions

Tobacco Cessation Counseling OTHER

Undergo JeffQuit group therapy

Also known as: Tobacco Cessation Counseling, Tobacco Counseling

Supportive care (JeffQuit group therapy)

Support Group Therapy OTHER

Undergo JeffQuit group therapy

Supportive care (JeffQuit group therapy)

Quality-of-Life Assessment OTHER

Ancillary studies

Also known as: Quality of Life Assessment, Quality-of-Life Assessment

Supportive care (JeffQuit group therapy)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• History of cancer
• Current smoker
• Willing to provide consent and participate in the JeffQuit program
• Referral by a Kimmel Cancer Center provider

You may not qualify if:

• Any significant active medical disorder or physical condition that could reasonably be expected to interfere with the ability of the patient to quit smoking as determined by the Principal Investigator (PI)
• Currently participating in another smoking cessation program
• Currently receiving chemotherapy or radiation therapy that would interfere with their ability to participate in the JeffQuit program
• Patients with evidence of a significant psychiatric disorder by history/examination that would prevent completion of the study will not be allowed to participate
• Patients with current alcohol or drug abuse
• Enrollment in active clinical trial/ experimental therapy within the prior 30 days
• Are in the terminal stages of illness

Sponsors & Collaborators

• Sidney Kimmel Cancer Center at Thomas Jefferson University: lead

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Related Links

• Sidney Kimmel Cancer Center at Thomas Jefferson University, an NCI-Designated Cancer Center
• Jefferson University Hospitals

MeSH Terms

Conditions

Neoplasms

Study Officials

• Andrew Newberg, MD

  Thomas Jefferson University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 28, 2015
• First Posted: October 29, 2015
• Study Start: August 1, 2013
• Primary Completion: November 1, 2014
• Last Updated: May 1, 2025

Record last verified: 2025-04

Locations

US (1)